Publizoom

Award notice Supplies

261A000098 - C.Central Medicamentos 2026 - 2026/0312

Notice published in Portuguese. The AI analysis summarises it for you in your language.

Public buyer
Unidade Local de Saúde Santa Maria, E.P.E.
Lisboa
Place of performance
Lisboa
Estimated value
€58,860 excl. VAT
Amount awarded
€58,860 excl. VAT
Planned end of contract
28 January 2027
likely re-tender around October 2026
Bids received
1
Procedure
Open procedure
Any company may submit a bid.
Publication
10 August 2026
Notice language
Portuguese

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

C.Central Medicamentos 2026 - 2026/0312

Awarded to

3 lots

  • Lote 5 - DENOsumab SOL INJ 60 MG/ 1ML SC BIOSSIMILAR SERINGA 1 ML (OSVYRTI)
  • Lote 9 - DENOsumab SOL INJ SC BIOSSIMILAR 120 MG (JUBEREQ)
  • Lote 11 - DENOsumab SOL INJ SC BIOSSIMILAR 120 MG (JUBEREQ)

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33652200

Winning prices for comparable contracts

A quarter below
€58,860
Median
€71,125
A quarter above
€382,013

Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
261A000098 - C.Central Medicamentos 2026 - 2026/0312 - ECULIzumab
Unidade Local de Saúde Santa Maria, E.P.E. · 10 August 2026
SAMSUNG BIOEPIS NL B. V €382,013
261A000098 - C.Central Medicamentos 2026 - 2026/0312 - ECULIzumab
Unidade Local de Saúde Santa Maria, E.P.E. · 10 August 2026
SAMSUNG BIOEPIS NL B. V €382,013
261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )
Unidade Local de Saúde Santa Maria, E.P.E. · 13 July 2026
Cencora 3PL Portugal €47,394
261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )
Unidade Local de Saúde Santa Maria, E.P.E. · 13 July 2026
CICLUM FARMA UNIPESSOAL, LDA €71,125

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 550788-2026.